Forefront Analytics LLC grew its holdings in shares of Athira Pharma, Inc. (NASDAQ:ATHA – Free Report) by 43.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,765 shares of the company’s stock after purchasing an additional 8,955 shares during the […]
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an […]
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily trading volume, of 309,500 […]
Annis Gardner Whiting Capital Advisors LLC raised its stake in Zillow Group, Inc. (NASDAQ:Z – Free Report) by 13.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,730 shares of the financial services provider’s stock after purchasing an additional 680 shares during the […]
JMP Securities reaffirmed their market outperform rating on shares of Athira Pharma (NASDAQ:ATHA – Free Report) in a research note released on Thursday morning, Benzinga reports. JMP Securities currently has a $19.00 price objective on the stock. Athira Pharma Price Performance Shares of ATHA stock opened at $2.52 on Thursday. Athira Pharma has a 1 […]